Erschienen in:
22.07.2019 | EDITORIAL
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
verfasst von:
Petra Zubin Maslov, MD, PhD, Navneet Narula, MD, Jagat Narula, MD, PhD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 3/2021
Einloggen, um Zugang zu erhalten
Excerpt
The patients with cardiac sarcoidosis are at a high risk of malignant ventricular tachyarrhythmias. The immunosuppressive therapy is effective but the diagnosis of the disease activity has remained a challenge. The assessment of the myocardial involvement is currently based on cardiac magnetic resonance imaging or non-specific diagnosis of myocardial inflammation by PET[FDG]-CT imaging. A more specific assessment of the disease activity should be of significant clinical value. With this end in view, Bravo and colleagues evaluated the applicability of somatostatin receptor (SSTR) imaging of myocardial inflammation.
1 These investigators have led the attempts at specific targeting of myocardial pathology in various disease states in the past as well. …